NO20063320L - Anvendelse av gaboxadol for behandling av insomni - Google Patents

Anvendelse av gaboxadol for behandling av insomni

Info

Publication number
NO20063320L
NO20063320L NO20063320A NO20063320A NO20063320L NO 20063320 L NO20063320 L NO 20063320L NO 20063320 A NO20063320 A NO 20063320A NO 20063320 A NO20063320 A NO 20063320A NO 20063320 L NO20063320 L NO 20063320L
Authority
NO
Norway
Prior art keywords
insomnia
treatment
gaboxadol
amount
patient
Prior art date
Application number
NO20063320A
Other languages
English (en)
Norwegian (no)
Inventor
Bjarke Ebert
Jonas Lundahl
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20063320(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20063320L publication Critical patent/NO20063320L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
NO20063320A 2003-12-18 2006-07-18 Anvendelse av gaboxadol for behandling av insomni NO20063320L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301877 2003-12-18
PCT/DK2004/000861 WO2005058313A1 (en) 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia

Publications (1)

Publication Number Publication Date
NO20063320L true NO20063320L (no) 2006-07-18

Family

ID=34684447

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063320A NO20063320L (no) 2003-12-18 2006-07-18 Anvendelse av gaboxadol for behandling av insomni

Country Status (17)

Country Link
EP (1) EP1720547A1 (ru)
JP (1) JP2007515415A (ru)
KR (1) KR20060103335A (ru)
CN (1) CN1893942A (ru)
AR (1) AR047154A1 (ru)
AU (1) AU2004298313A1 (ru)
BR (1) BRPI0415893A (ru)
CA (1) CA2550610A1 (ru)
EA (1) EA200600989A1 (ru)
IL (1) IL176239A0 (ru)
IS (1) IS8390A (ru)
MX (1) MXPA06006685A (ru)
NO (1) NO20063320L (ru)
SG (1) SG133601A1 (ru)
TW (1) TW200528098A (ru)
WO (1) WO2005058313A1 (ru)
ZA (1) ZA200602762B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
EP1906953A4 (en) * 2005-04-29 2009-05-20 Lundbeck & Co As H FORMS OF ACID SALTS AND BASIC SALTS OF GABOXADOL
AU2018331326A1 (en) * 2017-09-12 2020-03-19 Ovid Therapeutics Inc. Use of gaboxadol in the treatment of narcolepsy
CA3113644A1 (en) 2018-09-20 2020-03-26 Ovid Therapeutics Inc. Use of gaboxadol for the treatment of tourette syndrome, tics and stuttering
MX2021007224A (es) * 2018-12-17 2021-09-23 Ovid Therapeutics Inc Uso de gaboxadol para el tratamiento del trastorno del sue?o vigilia que no es de 24 horas.
US11364228B2 (en) 2019-12-18 2022-06-21 Ovid Therapeutics Inc. Gaboxadol for therapeutic treatment of 1p36 deletion syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
EP1389091A1 (en) * 2001-05-21 2004-02-18 H. Lundbeck A/S Granular preparations of gaboxadol

Also Published As

Publication number Publication date
WO2005058313A1 (en) 2005-06-30
CN1893942A (zh) 2007-01-10
TW200528098A (en) 2005-09-01
IL176239A0 (en) 2006-10-05
ZA200602762B (en) 2007-06-27
EA200600989A1 (ru) 2006-10-27
KR20060103335A (ko) 2006-09-28
EP1720547A1 (en) 2006-11-15
MXPA06006685A (es) 2006-08-23
SG133601A1 (en) 2007-07-30
BRPI0415893A (pt) 2007-01-09
AR047154A1 (es) 2006-01-11
IS8390A (is) 2006-03-30
AU2004298313A1 (en) 2005-06-30
CA2550610A1 (en) 2005-06-30
JP2007515415A (ja) 2007-06-14

Similar Documents

Publication Publication Date Title
EA200501319A1 (ru) Способы лечения боли введением антагониста фактора роста нервов и нестероидного противовоспалительного средства и содержащие их композиции
NO20050204L (no) Kombinasjoner av legemidler for behandling av neoplasmer
EA201301078A1 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
ATE457166T1 (de) Orale zusammensetzungen zur behandlung von diabetes
BRPI0510094A (pt) uso de flibanserina no tratamento pré-menstrual e outros distúrbios sexuais femininos
ATE389411T1 (de) Strontium verbindung zur behandlung von sub- dermalem weichteilschmerz
DK1263729T3 (da) Cykliske azaforbindelser til anvendelse til behandling af serotoninrealterede sygdomme
NO20064964L (no) Behandling av svekket respiratorisk funksjon
NO20054371L (no) Somatostatin-dopamin kimaere analoger
DE502005008058D1 (de) Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
HK1082203A1 (en) Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
CY1115690T1 (el) Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων
NO20063320L (no) Anvendelse av gaboxadol for behandling av insomni
DE122009000036I2 (de) Verwendung von Dapoxetin, ein selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Dysfunktion
NO20092018L (no) Fremgangsmater for a behandle depresjon
MX2009003532A (es) Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina.
ATE499933T1 (de) Verwendung von betain zur behandlung von claudicatio intermittens
EA200501865A1 (ru) Аналоги тиовольфраматов и их применение
BR0111900A (pt) Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca
EA200601853A1 (ru) Лечение нарушенной дыхательной функции
MXPA05013975A (es) Tratamiento de enfermedades asociadas con amiloide y epileptogenesis.
NO20024545L (no) Fremgangsmåte for behandling av kongestiv hjertefeil
RS52038B (en) USE OF 7-BUTOXYIMINOMETHYLAMPTOTECIN FOR THE TREATMENT OF NON-PLASMA NEOPLASMS
BR0317772A (pt) Método de tratamento de um distúrbio de comportamento, uso de um composto, e, agente terapêutico para um distúrbio de comportamento

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104